Risk reduction and screening of cancer in hereditary breast-ovarian cancer syndromes: ESMO Clinical Practice Guideline
Open accessThe DOI matches its Crossref record; 107 of the 107 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers
Kuchenbaecker, K. B., Hopper, J. L., Barnes, D. R., Phillips, K.-A., Mooij, T. M., Roos-Blom, M.-J., Jervis, S., van Leeuwen, F. E., Milne, R. L., Andrieu, N., et al. (2017) · JAMA · doi:10.1001/jama.2017.7112 · Cited by 2,954
Self-citationMammographic Density and the Risk and Detection of Breast Cancer
Boyd, N. F., Guo, H., Martin, L. J., Sun, L., Stone, J., Fishell, E., Jong, R. A., Hislop, G., Chiarelli, A., Minkin, S., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa062790 · Cited by 2,478
Adjuvant Olaparib for Patients with BRCA1 - or BRCA2 -Mutated Breast Cancer
Tutt, A. N. J., Garber, J. E., Kaufman, B., Viale, G., Fumagalli, D., Rastogi, P., Gelber, R. D., de Azambuja, E., Fielding, A., Balmaña, J., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2105215 · Cited by 1,729
Self-citationCancer Risks in BRCA2 Mutation Carriers
Breast Cancer Linkage Consortium, T. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.15.1310 · Cited by 1,527
Domchek, S. M. (2010) · JAMA · doi:10.1001/jama.2010.1237 · Cited by 1,494
Self-citationBreast Cancer Risk Genes — Association Analysis in More than 113,000 Women
Breast Cancer Association Consortium (2021) · New England Journal of Medicine · doi:10.1056/nejmoa1913948 · Cited by 1,136
Daly, M. B., Pal, T., Berry, M. P., Buys, S. S., Dickson, P., Domchek, S. M., Elkhanany, A., Friedman, S., Goggins, M., Hutton, M. L., et al. (2021) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2021.0001 · Cited by 1,112
Self-citationThe CHEK2-Breast Cancer Consortium (2002) · Nature Genetics · doi:10.1038/ng879 · Cited by 1,104
A Population-Based Study of Genes Previously Implicated in Breast Cancer
Hu, C., Hart, S. N., Gnanaolivu, R., Huang, H., Lee, K. Y., Na, J., Gao, C., Lilyquist, J., Yadav, S., Boddicker, N. J., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2005936 · Cited by 816
Self-citationAshkenazi Jewish population frequencies for common mutations in BRCA1 and BRCA2
Roa, B. B., Boyd, A. A., Volcik, K., & Richards, C. S. (1996) · Nature Genetics · doi:10.1038/ng1096-185 · Cited by 770
Inherited Mutations in Women With Ovarian Carcinoma
Norquist, B. M., Harrell, M. I., Brady, M. F., Walsh, T., Lee, M. K., Gulsuner, S., Bernards, S. S., Casadei, S., Yi, Q., Burger, R. A., et al. (2016) · JAMA Oncology · doi:10.1001/jamaoncol.2015.5495 · Cited by 769
Lee, A., Mavaddat, N., Wilcox, A. N., Cunningham, A. P., Carver, T., Hartley, S., Babb de Villiers, C., Izquierdo, A., Simard, J., Schmidt, M. K., et al. (2019) · Genetics in Medicine · doi:10.1038/s41436-018-0406-9 · Cited by 721
Impact of Oophorectomy on Cancer Incidence and Mortality in Women With a BRCA1 or BRCA2 Mutation
Finch, A. P. M., Lubinski, J., Møller, P., Singer, C. F., Karlan, B., Senter, L., Rosen, B., Maehle, L., Ghadirian, P., Cybulski, C., et al. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2013.53.2820 · Cited by 664
Goggins, M., Overbeek, K. A., Brand, R., Syngal, S., Del Chiaro, M., Bartsch, D. K., Bassi, C., Carrato, A., Farrell, J., Fishman, E. K., et al. (2020) · Gut · doi:10.1136/gutjnl-2019-319352 · Cited by 659
Dykewicz, C. A. (2001) · Clinical Infectious Diseases · doi:10.1086/321805 · Cited by 636
Bone health in cancer: ESMO Clinical Practice Guidelines
Coleman, R., Hadji, P., Body, J.-J., Santini, D., Chow, E., Terpos, E., Oudard, S., Bruland, Ø., Flamen, P., Kurth, A., et al. (2020) · Annals of Oncology · doi:10.1016/j.annonc.2020.07.019 · Cited by 549
Moderate Alcohol Consumption During Adult Life, Drinking Patterns, and Breast Cancer Risk
Chen, W. Y., Rosner, B., Hankinson, S. E., Colditz, G. A., & Willett, W. C. (2011) · JAMA · doi:10.1001/jama.2011.1590 · Cited by 509
Daly, M. B., Pilarski, R., Yurgelun, M. B., Berry, M. P., Buys, S. S., Dickson, P., Domchek, S. M., Elkhanany, A., Friedman, S., Garber, J. E., et al. (2020) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2020.0017 · Cited by 505
Self-citationKuhl, C., Weigel, S., Schrading, S., Arand, B., Bieling, H., König, R., Tombach, B., Leutner, C., Rieber-Brambs, A., Nordhoff, D., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.23.0839 · Cited by 501
Self-citationLambertini, M., Peccatori, F. A., Demeestere, I., Amant, F., Wyns, C., Stukenborg, J.-B., Paluch-Shimon, S., Halaska, M. J., Uzan, C., Meissner, J., et al. (2020) · Annals of Oncology · doi:10.1016/j.annonc.2020.09.006 · Cited by 500
Self-citationHereditary diffuse gastric cancer: updated clinical practice guidelines
Blair, V. R., McLeod, M., Carneiro, F., Coit, D. G., D'Addario, J. L., van Dieren, J. M., Harris, K. L., Hoogerbrugge, N., Oliveira, C., van der Post, R. S., et al. (2020) · The Lancet Oncology · doi:10.1016/s1470-2045(20)30219-9 · Cited by 491
Yang, X., Leslie, G., Doroszuk, A., Schneider, S., Allen, J., Decker, B., Dunning, A. M., Redman, J., Scarth, J., Plaskocinska, I., et al. (2020) · Journal of Clinical Oncology · doi:10.1200/jco.19.01907 · Cited by 432
Self-citationContrast‐enhanced MRI for breast cancer screening
Mann, R. M., Kuhl, C. K., & Moy, L. (2019) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.26654 · Cited by 356
Self-citationPopulation-based screening for breast and ovarian cancer risk due to BRCA1 and BRCA2
Gabai-Kapara, E., Lahad, A., Kaufman, B., Friedman, E., Segev, S., Renbaum, P., Beeri, R., Gal, M., Grinshpun-Cohen, J., Djemal, K., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1415979111 · Cited by 342
Self-citationGuidelines for the Li–Fraumeni and heritable TP53-related cancer syndromes
The European Reference Network GENTURIS, Frebourg, T., Bajalica Lagercrantz, S., Oliveira, C., Magenheim, R., & Evans, D. G. (2020) · European Journal of Human Genetics · doi:10.1038/s41431-020-0638-4 · Cited by 342
Self-citationRisk of cancer other than breast or ovarian in individuals with BRCA1 and BRCA2 mutations
Moran, A., O’Hara, C., Khan, S., Shack, L., Woodward, E., Maher, E. R., Lalloo, F., & Evans, D. G. R. (2012) · Familial Cancer · doi:10.1007/s10689-011-9506-2 · Cited by 307
Self-citationRiedl, C. C., Luft, N., Bernhart, C., Weber, M., Bernathova, M., Tea, M.-K. M., Rudas, M., Singer, C. F., & Helbich, T. H. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.56.8626 · Cited by 300
Cancer Risks Associated With BRCA1 and BRCA2 Pathogenic Variants
Li, S., Silvestri, V., Leslie, G., Rebbeck, T. R., Neuhausen, S. L., Hopper, J. L., Nielsen, H. R., Lee, A., Yang, X., McGuffog, L., et al. (2022) · Journal of Clinical Oncology · doi:10.1200/jco.21.02112 · Cited by 287
Self-citationRisk-reducing mastectomy for the prevention of primary breast cancer
Carbine, N. E., Lostumbo, L., Wallace, J., & Ko, H. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002748.pub4 · Cited by 266
The Multicenter Cancer of Pancreas Screening Study: Impact on Stage and Survival
Dbouk, M., Katona, B. W., Brand, R. E., Chak, A., Syngal, S., Farrell, J. J., Kastrinos, F., Stoffel, E. M., Blackford, A. L., Rustgi, A. K., et al. (2022) · Journal of Clinical Oncology · doi:10.1200/jco.22.00298 · Cited by 247
Page, E. C., Bancroft, E. K., Brook, M. N., Assel, M., Hassan Al Battat, M., Thomas, S., Taylor, N., Chamberlain, A., Pope, J., Raghallaigh, H. N., et al. (2019) · European Urology · doi:10.1016/j.eururo.2019.08.019 · Cited by 247
Self-citationLi, X., You, R., Wang, X., Liu, C., Xu, Z., Zhou, J., Yu, B., Xu, T., Cai, H., & Zou, Q. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-1465 · Cited by 234
Shu, C. A., Pike, M. C., Jotwani, A. R., Friebel, T. M., Soslow, R. A., Levine, D. A., Nathanson, K. L., Konner, J. A., Arnold, A. G., Bogomolniy, F., et al. (2016) · JAMA Oncology · doi:10.1001/jamaoncol.2016.1820 · Cited by 232
Self-citationCarver, T., Hartley, S., Lee, A., Cunningham, A. P., Archer, S., Babb de Villiers, C., Roberts, J., Ruston, R., Walter, F. M., Tischkowitz, M., et al. (2021) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-20-1319 · Cited by 228
Modifiers of Cancer Risk in BRCA1 and BRCA2 Mutation Carriers: A Systematic Review and Meta-Analysis
Friebel, T. M., Domchek, S. M., & Rebbeck, T. R. (2014) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/dju091 · Cited by 225
Self-citationPurpose of Quality Standards for Infectious Diseases
Gross, P. A., Barrett, T. L., Dellinger, E. P., Krause, P. J., Martone, W. J., McGowan, J. E., Sweet, R. L., & Wenzel, R. P. (1994) · Clinical Infectious Diseases · doi:10.1093/clinids/18.3.421 · Cited by 223
Chlebowski, R. T., Rohan, T. E., Manson, J. E., Aragaki, A. K., Kaunitz, A., Stefanick, M. L., Simon, M. S., Johnson, K. C., Wactawski-Wende, J., O’Sullivan, M. J., et al. (2015) · JAMA Oncology · doi:10.1001/jamaoncol.2015.0494 · Cited by 211
Rosenthal, A. N., Fraser, L. S. M., Philpott, S., Manchanda, R., Burnell, M., Badman, P., Hadwin, R., Rizzuto, I., Benjamin, E., Singh, N., et al. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2016.69.9330 · Cited by 209
Self-citationManickam, K., Buchanan, A. H., Schwartz, M. L. B., Hallquist, M. L. G., Williams, J. L., Rahm, A. K., Rocha, H., Savatt, J. M., Evans, A. E., Butry, L. M., et al. (2018) · JAMA Network Open · doi:10.1001/jamanetworkopen.2018.2140 · Cited by 208
Cancer Risks Associated With BRCA1 and BRCA2 Pathogenic Variants.
Li, S., Silvestri, V., Leslie, G., Rebbeck, T. R., Neuhausen, S. L., Hopper, J. L., Nielsen, H. R., Lee, A., Yang, X., McGuffog, L., et al. (2021) · Kölner Universitäts PublikationsServer (Universität zu Köln) · doi:10.17863/cam.78454 · Cited by 207
Self-citationSurvival after bilateral risk-reducing mastectomy in healthy BRCA1 and BRCA2 mutation carriers
Heemskerk-Gerritsen, B. A. M., Jager, A., Koppert, L. B., Obdeijn, A. I.-M., Collée, M., Meijers-Heijboer, H. E. J., Jenner, D. J., Oldenburg, H. S. A., van Engelen, K., de Vries, J., et al. (2019) · Breast Cancer Research and Treatment · doi:10.1007/s10549-019-05345-2 · Cited by 197
ESGO/ISUOG/IOTA/ESGE Consensus Statement on pre-operative diagnosis of ovarian tumors
Timmerman, D., Planchamp, F., Bourne, T. H., Landolfo, C., du Bois, A., Chiva, L. M., Cibula, D., Concin, N., Fischerová, D., Froyman, W., et al. (2021) · International Journal of Gynecological Cancer · doi:10.1136/ijgc-2021-002565 · Cited by 191
Self-citationUS Preventive Services Task Force, Owens, D. K., Davidson, K. W., Krist, A. H., Barry, M. J., Cabana, M., Caughey, A. B., Doubeni, C. A., Epling, J. W., Kubik, M., et al. (2019) · JAMA · doi:10.1001/jama.2019.11885 · Cited by 189
Tamoxifen and Risk of Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers
Phillips, K.-A., Milne, R. L., Rookus, M. A., Daly, M. B., Antoniou, A. C., Peock, S., Frost, D., Easton, D. F., Ellis, S., Friedlander, M. L., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.47.8313 · Cited by 171
Self-citationHall, M. J., Bernhisel, R., Hughes, E., Larson, K., Rosenthal, E. T., Singh, N. A., Lancaster, J. M., & Kurian, A. W. (2021) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-20-0448 · Cited by 165
Brinton, L. A., Cook, M. B., McCormack, V., Johnson, K. C., Olsson, H., Casagrande, J. T., Cooke, R., Falk, R. T., Gapstur, S. M., Gaudet, M. M., et al. (2014) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djt465 · Cited by 164
Population Frequency of Germline BRCA1/2 Mutations
Maxwell, K. N., Domchek, S. M., Nathanson, K. L., & Robson, M. E. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2016.67.0554 · Cited by 164
Self-citationThe complex genetic landscape of familial breast cancer
Melchor, L., & Benítez, J. (2013) · Human Genetics · doi:10.1007/s00439-013-1299-y · Cited by 163
Cancer Surveillance Guideline for individuals with PTEN hamartoma tumour syndrome
Tischkowitz, M. D., Colas, C., Pouwels, S., Hoogerbrugge, N., PHTS Guideline Development Group, Bisseling, T. M., Bubien, V., Caux, F. A., Chabbert‐Buffet, N., Colas, C., et al. (2020) · European Journal of Human Genetics · doi:10.1038/s41431-020-0651-7 · Cited by 158
Self-citationNelson, H. D., Pappas, M., Cantor, A., Haney, E., & Holmes, R. (2019) · JAMA · doi:10.1001/jama.2019.8430 · Cited by 145
Näslund‐Koch, C., Nordestgaard, B. G., & Bojesen, S. E. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2015.63.3594 · Cited by 143
Skates, S. J., Greene, M. H., Buys, S. S., Mai, P. L., Brown, P., Piedmonte, M., Rodriguez, G., Schorge, J. O., Sherman, M., Daly, M. B., et al. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-2750 · Cited by 140
Self-citationRazdan, S. N., Patel, V., Jewell, S., & McCarthy, C. M. (2015) · Quality of Life Research · doi:10.1007/s11136-015-1181-6 · Cited by 138
Barnes, D. R., Rookus, M. A., McGuffog, L., Leslie, G., Mooij, T. M., Dennis, J., Mavaddat, N., Adlard, J., Ahmed, M., Aittomäki, K., et al. (2020) · Genetics in Medicine · doi:10.1038/s41436-020-0862-x · Cited by 138
Self-citationGordhandas, S., Norquist, B. M., Pennington, K. P., Yung, R. L., Laya, M. B., & Swisher, E. M. (2019) · Gynecologic Oncology · doi:10.1016/j.ygyno.2018.12.014 · Cited by 128
Metcalfe, K. A., Cil, T. D., Semple, J. L., Li, L. D. X., Bagher, S., Zhong, T., Virani, S., Narod, S. A., & Pal, T. (2015) · Annals of Surgical Oncology · doi:10.1245/s10434-015-4761-3 · Cited by 126
Phi, X.-A., Saadatmand, S., de Bock, G. H., Warner, E., Sardanelli, F., Leach, M. O., Riedl, C. C., Trop, I., Hooning, M. J., Mandel, R., et al. (2016) · British Journal of Cancer · doi:10.1038/bjc.2016.32 · Cited by 122
Berek, J. S., Chalas, E., Edelson, M. I., Moore, D. H., Burke, W. M., Cliby, W. A., & Berchuck, A. (2010) · Obstetrics and Gynecology · doi:10.1097/aog.0b013e3181ec5fc1 · Cited by 120
Overbeek, K. A., Goggins, M. G., Dbouk, M., Levink, I. J. M., Koopmann, B. D. M., Chuidian, M., Konings, I. C. A. W., Paiella, S., Earl, J., Fockens, P., et al. (2022) · Gastroenterology · doi:10.1053/j.gastro.2021.10.014 · Cited by 114
Ringwald, J., Wochnowski, C., Bosse, K., Giel, K. E., Schäffeler, N., Zipfel, S., & Teufel, M. (2016) · Journal of Genetic Counseling · doi:10.1007/s10897-016-9949-6 · Cited by 114
Liu, Y. L., Breen, K. E., Catchings, A., Ranganathan, M., Latham, A. J., Goldfrank, D. J., Grisham, R. N., Roche, K. L., Frey, M. K., Chi, D. S., et al. (2021) · JCO Oncology Practice · doi:10.1200/op.21.00382 · Cited by 110
Endometrial Cancer Risk in Women With Germline BRCA1 or BRCA2 Mutations: Multicenter Cohort Study
de Jonge, M. M., de Kroon, C. D., Jenner, D. J., Oosting, J., de Hullu, J. A., Mourits, M. J. E., Gómez-García, E. B., Ausems, M. G. E. M., Collée, J. M., van Engelen, K., et al. (2021) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djab036 · Cited by 107
Magnetic Resonance Imaging in Screening of Breast Cancer
Gao, Y., Reig, B., Heacock, L. C., Bennett, D. L., Heller, S. L., & Moy, L. P. (2020) · Radiologic Clinics of North America · doi:10.1016/j.rcl.2020.09.004 · Cited by 105
Steenbeek, M. P., Harmsen, M. G., Hoogerbrugge, N., de Jong, M. A., Maas, A. H. E. M., Prins, J. B., Bulten, J., Teerenstra, S., van Bommel, M. H. D., van Doorn, H. C., et al. (2021) · JAMA Oncology · doi:10.1001/jamaoncol.2021.1590 · Cited by 102
Tischkowitz, M. D., Balmañà, J., Foulkes, W. D., James, P. A., Ngeow, J. Y. Y., Schmutzler, R. K., Voian, N. C., Wick, M. J., Stewart, D. R., & Pal, T. (2021) · Genetics in Medicine · doi:10.1038/s41436-021-01151-8 · Cited by 99
kConFab Investigators, Hopper, J. L., Dite, G. S., MacInnis, R. J., Liao, Y., Zeinomar, N., Knight, J. A., Southey, M. C., Milne, R. L., Chung, W. K., et al. (2018) · Breast Cancer Research · doi:10.1186/s13058-018-1056-1 · Cited by 94
Self-citationScreening Guidelines Update for Average-Risk and High-Risk Women
Lee, C. S., Monticciolo, D. L., & Moy, L. P. (2019) · American Journal of Roentgenology · doi:10.2214/ajr.19.22205 · Cited by 86
Buonomo, B., Massarotti, C., Dellino, M., Anserini, P., Ferrari, A., Campanella, M., Magnotti, M., Stefano, C. D., Peccatori, F. A., & Lambertini, M. (2021) · BMC Medicine · doi:10.1186/s12916-021-02081-7 · Cited by 83
Self-citationBober, S. L., Recklitis, C. J., Bakan, J., Garber, J. E., & Patenaude, A. F. (2015) · The Journal of Sexual Medicine · doi:10.1111/jsm.12713 · Cited by 78
Self-citationPopulation-based genetic testing of asymptomatic women for breast and ovarian cancer susceptibility
Rowley, S. M., Mascarenhas, L., Devereux, L. M., Li, N., Amarasinghe, K. C., Zethoven, M., Lee, J. E. A., Lewis, A. L., Morgan, J. A., Limb, S., et al. (2018) · Genetics in Medicine · doi:10.1038/s41436-018-0277-0 · Cited by 78
Giannakeas, V., & Narod, S. A. (2017) · Breast Cancer Research and Treatment · doi:10.1007/s10549-017-4476-1 · Cited by 73
Lee, K., Seifert, B. A., Shimelis, H., Ghosh, R., Crowley, S. B., Carter, N. J., Doonanco, K., Foreman, A. K. M., Ritter, D., Jimenez, S., et al. (2018) · Genetics in Medicine · doi:10.1038/s41436-018-0361-5 · Cited by 72
Kehm, R. D., Genkinger, J. M., MacInnis, R. J., John, E. M., Phillips, K., Dite, G. S., Milne, R. L., Zeinomar, N., Liao, Y., Knight, J. A., et al. (2020) · Cancer Research · doi:10.1158/0008-5472.can-19-1847 · Cited by 69
Self-citationNebgen, D. R., Hurteau, J. A., Holman, L. L., Bradford, A. M., Munsell, M. F., Soletsky, B. R., Sun, C. C., Chisholm, G. B., & Lu, K. H. (2018) · Gynecologic Oncology · doi:10.1016/j.ygyno.2018.04.564 · Cited by 67
Rizzolo, P., Zelli, V., Silvestri, V., Valentini, V., Zanna, I., Bianchi, S., Masala, G., Spinelli, A. M., Tibiletti, M. G., Russo, A. D., et al. (2019) · International Journal of Cancer · doi:10.1002/ijc.32106 · Cited by 65
Body Image After Bilateral Prophylactic Mastectomy: An Integrative Literature Review
McGaughey, A. (2006) · Journal of Midwifery & Women's Health · doi:10.1016/j.jmwh.2006.07.002 · Cited by 64
Gaba, F., Robbani, S., Singh, N., McCluggage, W. G., Wilkinson, N., Ganesan, R., Bryson, G., Rowlands, G. L., Tyson, C., Arora, R., et al. (2020) · International Journal of Gynecological Cancer · doi:10.1136/ijgc-2020-001541 · Cited by 63
Self-citationHuber, D., Seitz, S., Kast, K., Emons, G., & Ortmann, O. (2021) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-021-03629-z · Cited by 63
Schrijver, L. H., Olsson, H. L., Phillips, K., Terry, M. B., Goldgar, D. E., Kast, K., Engel, C., Mooij, T. M., Adlard, J., Barrowdale, D., et al. (2018) · JNCI Cancer Spectrum · doi:10.1093/jncics/pky023 · Cited by 58
Self-citationGeuzinge, H. A., Obdeijn, I.-M., Rutgers, E. J. T., Saadatmand, S., Mann, R. M., Oosterwijk, J. C., Tollenaar, R. A. �. �., van Zuidewijn, D. B. W. D. R., Lobbes, M. B. I., Riet, M. V. ’., et al. (2020) · JAMA Oncology · doi:10.1001/jamaoncol.2020.2922 · Cited by 57
Lombardi, L., Bramanti, S. M., Babore, A., Stuppia, L., Trumello, C., Antonucci, I., & Cavallo, A. (2019) · Supportive Care in Cancer · doi:10.1007/s00520-019-04918-7 · Cited by 56
Glassey, R., Ives, A. D., Saunders, C. M., & Musiello, T. (2016) · The Breast · doi:10.1016/j.breast.2016.05.012 · Cited by 53
Cicero, G., Luca, R. D., Dorangricchia, P., Coco, G. L., Guarnaccia, C., Fanale, D., Calò, V., & Russo, A. G. (2017) · Journal of Genetic Counseling · doi:10.1007/s10897-017-0072-0 · Cited by 51
Vreemann, S., van Zelst, J. C. M., Schlooz-Vries, M. S., Bult, P., Hoogerbrugge, N., Karssemeijer, N., Gubern‐Mérida, A., & Mann, R. M. (2018) · Breast Cancer Research · doi:10.1186/s13058-018-1019-6 · Cited by 49
Nonsurgical Prevention Strategies in BRCA1 and BRCA2 Mutation Carriers
Singer, C. F. (2020) · Breast Care · doi:10.1159/000507503 · Cited by 49
Chhoda, A., Vodusek, Z., Wattamwar, K., Mukherjee, E. M., Gunderson, C. G., Grimshaw, A. A., Sharma, A. R., Ahuja, N., Kastrinos, F., & Farrell, J. J. (2021) · Gastroenterology · doi:10.1053/j.gastro.2021.11.021 · Cited by 47
Bosch, N., Parera, N., Gadea, N., Brunet, J., y Cajal, T. R., Torres, A., Graña, B., Velasco, À., Darder, E., Mensa, I., et al. (2012) · The Breast · doi:10.1016/j.breast.2012.02.004 · Cited by 45
Preimplantation genetic testing for carriers of BRCA1/2 pathogenic variants
Vuković, P., Peccatori, F. A., Massarotti, C., Miralles, M. S., Beketić-Orešković, L., & Lambertini, M. (2020) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2020.103201 · Cited by 45
Self-citationHow Protective are Nipple-Sparing Prophylactic Mastectomies in BRCA1 and BRCA2 Mutation Carriers?
Garstka, M., Henriquez, A., Kelly, B. N., Webster, A. J., Khubchandani, J. A., Hughes, K. S., Nguyen, A., Oseni, T. O., Specht, M. C., Coopey, S. B., et al. (2021) · Annals of Surgical Oncology · doi:10.1245/s10434-021-10445-9 · Cited by 45
Germline TP53 Testing in Breast Cancers: Why, When and How?
Evans, D. G., Woodward, E. R., Bajalica‐Lagercrantz, S., Oliveíra, C., & Frébourg, T. (2020) · Cancers · doi:10.3390/cancers12123762 · Cited by 42
Self-citationUse of antidepressants and risk of epithelial ovarian cancer
Mørch, L. S., Dehlendorff, C., Baandrup, L., Friis, S., & Kjær, S. K. (2017) · International Journal of Cancer · doi:10.1002/ijc.30919 · Cited by 40
Li, H., Terry, M. B., Antoniou, A. C., Phillips, K., Kast, K., Mooij, T. M., Engel, C., Noguès, C., Stoppa‐Lyonnet, D., Lasset, C., et al. (2019) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-19-0546 · Cited by 40
Self-citationTerry, M. B., Liao, Y., Kast, K., Antoniou, A. C., McDonald, J. A., Mooij, T. M., Engel, C., Noguès, C., Buecher, B., Mari, V., et al. (2018) · JNCI Cancer Spectrum · doi:10.1093/jncics/pky078 · Cited by 37
Self-citationMichaelson‐Cohen, R., Gabizon–Peretz, S., Armon, S., Srebnik, N., Mor, P., Tomer, A., Levy‐Lahad, E., & Paluch–Shimon, S. (2021) · European Journal of Cancer · doi:10.1016/j.ejca.2021.02.007 · Cited by 37
Self-citationWood, M. E., McKinnon, W. C., & Garber, J. E. (2020) · The Breast Journal · doi:10.1111/tbj.13969 · Cited by 36
BRCA1/2 genetic testing uptake and psychosocial outcomes in men
Graves, K. D., Gatammah, R., Peshkin, B. N., Krieger, A., Gell, C., Valdimarsdottir, H. B., & Schwartz, M. D. (2011) · Familial Cancer · doi:10.1007/s10689-011-9425-2 · Cited by 35
Inherited Mutations in Chinese Men With Prostate Cancer
Zhu, Y., Yu, W., Zeng, H., Li, Y., Ng, C., Zhou, F., He, C., Sun, G., Ni, Y., Chiu, P. K., et al. (2021) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2021.7010 · Cited by 26
Kershaw, V. F., Hickey, I., Wyld, L., & Jha, S. (2021) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2021.08.001 · Cited by 24
Listøl, W., Høberg‐Vetti, H., Eide, G. E., & Bjorvatn, C. (2017) · Hereditary Cancer in Clinical Practice · doi:10.1186/s13053-016-0062-5 · Cited by 22
Distress and Psychosocial Needs of a Heterogeneous High Risk Familial Cancer Population
Power, T. E., Robinson, J. W., Bridge, P. J., Bernier, F. P., & Gilchrist, D. M. (2011) · Journal of Genetic Counseling · doi:10.1007/s10897-010-9344-7 · Cited by 21
Nguyen‐Dumont, T., Dowty, J. G., MacInnis, R. J., Steen, J. A., Riaz, M., Dugué, P., Renault, A., Hammet, F., Mahmoodi, M. S., Theys, D., et al. (2021) · Cancers · doi:10.3390/cancers13071495 · Cited by 21
Discouraging Elective Genetic Testing of Minors: A Norm under Siege in a New Era of Genomic Medicine
Hercher, L. (2019) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a036657 · Cited by 20
Conduit, C., Milne, R. L., Friedlander, M. L., & Phillips, K. (2021) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-21-0141 · Cited by 19
Self-citationPujol, P., Roca, L., Lortholary, A. H., et al. (2020) · Journal of Clinical Oncology · doi:10.1200/jco.2020.38.15_suppl.1534 · Cited by 10
Rosenthal, M. H., Wolpin, B. M., & Yurgelun, M. B. B. (2021) · Gastroenterology · doi:10.1053/j.gastro.2021.12.259 · Cited by 6
Cited by
Early breast cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
Loibl, S., André, F., Bachelot, T., Barrios, C. H., Bergh, J., Burstein, H. J., Cardoso, M. J., Carey, L. A., Dawood, S., Del Mastro, L., et al. (2024) · Annals of Oncology · doi:10.1016/j.annonc.2023.11.016 · Cited by 1,008
Self-citationGonzález-Martín, A., Harter, P., Leary, A., Lorusso, D., Miller, R. E., Pothuri, B., Ray-Coquard, I., Tan, D. S. P., Bellet, E., Oaknin, A., et al. (2023) · Annals of Oncology · doi:10.1016/j.annonc.2023.07.011 · Cited by 449
Self-citationCardoso, F., Paluch-Shimon, S., Schumacher-Wulf, E., Matos, L., Gelmon, K., Aapro, M. S., Bajpai, J., Barrios, C. H., Bergh, J., Bergsten-Nordström, E., et al. (2024) · The Breast · doi:10.1016/j.breast.2024.103756 · Cited by 237
Self-citationThe impact of AI on modern oncology from early detection to personalized cancer treatment
Li, J., Zhang, L., Yu, Z., Bao, Z., Li, D., & Wang, L. (2026) · npj Precision Oncology · doi:10.1038/s41698-026-01276-6 · Cited by 24
“The presence of gPVs in the BRCA1 and BRCA2 genes, which predispose carriers to breast and ovarian cancers, is one of the most well-characterised hereditary signatures in oncology 189 .”
Metadata
- Authors
- Sessa, C., Balmaña, J., Bober, S. L., Cardoso, M. J., Colombo, N., Curigliano, G., Domchek, S. M., Evans, D. G., Fischerova, D., Harbeck, N., Kuhl, C., Lemley, B., Levy-Lahad, E., Lambertini, M., Ledermann, J. A., Loibl, S., Phillips, K.-A., & Paluch-Shimon, S.
- Venue
- Annals of Oncology
- Publisher
- Elsevier BV
- Published
- 2023-01
- Volume
- 34
- Issue
- 1
- Pages
- 33-47
- ISSN
- 0923-7534 (ISSN-L)
- OpenAlex
- W4307401062
- Cited by
- 295
- References
- 107
- FWCI
- 28.54
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.